Empty bottles, rising risks: A case-crossover study on psychotherapeutic medication depletion and suicide triggers
Austin Porter1, Allen M Smith2, Srinivasa B Gokarakonda3
1Fay W. Boozman College of Public Health, Department of Health Policy and Management, University of Arkansas for Medical Sciences, Little Rock, AR 72205, United States of America; Arkansas Department of Health, Little Rock, AR 72205, United States of America.
Objective:
The use of psychotherapeutic medications can reduce the risk of suicide among people with mental health disorders, but little is known about the impact of exhausting these medications. This study analyzes the temporal relationship between running out of psychotherapeutic medications and suicide using a case-crossover study design.
Methods:
Pharmacy and medical claims data from the Arkansas All-Payers Claims Database were linked to death certificates to identify decedents of suicide from 2013 through 2021. Psychotherapeutic medications were categorized using a National Drug Code (NDC) ontology from First DataBank®. The dispensed date and days' supply from pharmacy claims estimated when a decedent would exhaust any prescribed psychotherapeutic. A dichotomous variable indicated if a decedent exhausted at least one psychotherapeutic during the hazard window - the seven days leading up to and including the date of death. This exposure was compared to 11 control windows - the 11 weeks immediately preceding the hazard window. Conditional logistic regression analysis estimated the odds of exhausting at least one medication during the hazard window relative to the control windows.
Results:
Among 853 decedents who received 4375 psychotherapeutic prescriptions, 17.0 % exhausted at least one psychotherapeutic in the hazard window, the highest among all study windows. There was a 46 % increase in the odds of exhausting at least one psychotherapeutic during the hazard window compared to the control windows (AOR: 1.46; p = 0.0001).
Conclusion:
There is a temporal relationship between exhausting at least one psychotherapeutic medication and suicide, highlighting the need for close monitoring of medication supply for patients treated with psychotherapeutics.
More Related Videos
09:29Investigating Drivers of Antireward in Addiction Behavior with Anatomically Specific Single-Cell Gene Expression Methods
Published on: August 4, 2022
05:56Author Spotlight: Establishing a Rodent Model for Investigating Depression Factors in Traditional Mongolian Medicine
Published on: October 27, 2023
Related Concept Videos
Antidepressant Drugs: MAOIs and Other Agents
Drug Therapy
Antianxiety Medications
Nonlinear Pharmacokinetics: Dependence of Elimination Half-Life and Dose Clearance
A study on guinea pigs examined the...
Psychological and Sociocultural Causes of Schizophrenia
Depressive Disorders: Etiology
Biological Factors in Depression
Biological predispositions significantly influence the risk of developing depressive disorders. Genetic studies highlight the role of variations in the serotonin transporter...
Desensitization and Tachyphylaxis
